Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas [Phase 2]
Phase 2 clinical trial evaluating radiation therapy with temozolomide and lomustine in young patients with newly diagnosed gliomas; complete…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma [Phase 2]
A Phase 2 trial evaluating dose-escalated MR spectroscopy imaging-guided radiation therapy for glioblastoma has been terminated, with result…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma [NA]
This clinical trial update notes the termination of a study evaluating multimodal imaging analysis during Bevacizumab treatment in patients …
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating the effectiveness and safety of combining chemotherapy with radiation therapy in patients with newly diagn…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 CAR-T cell therapy targeting MUC1 is being investigated for glioblastoma, colorectal cancer, and gastric cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: FR901228 in Treating Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated FR901228 in adults with recurrent high-grade gliomas; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma [Phase 1]
Phase 1 study of GDC-0084 in patients with progressive or recurrent high-grade glioma has completed. Indications studied include glioblastom…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma [Phase 2]
A Phase 2 trial evaluated bevacizumab (Avastin) in combination with radiotherapy for elderly patients with glioblastoma; the study has compl…
-
CLINICAL_TRIALS research · 2016-10-20Clinical Trial Update: Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study [Phase 1, Phase 2]
A Phase 1/2 pilot study evaluating a ketogenic diet as an adjunct to salvage chemotherapy for recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma [Phase 3]
Phase 3 trial evaluating temozolomide with radiation therapy with or without bevacizumab in newly diagnosed glioblastoma; study completed wi…
-
CLINICAL_TRIALS research · 2016-10-10Clinical Trial Update: Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating the combination of sunitinib, temozolomide, and radiation therapy for gliobla…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating an NY-ESO-1 vaccine therapy with or without sirolimus in patients whose tumors express NY-ESO-1.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme [NA]
A Phase II trial evaluating neoadjuvant temozolomide before concurrent temozolomide with accelerated hypofractionated external beam radiothe…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma [Phase 1, Phase 2]
Completed Phase I/II adaptive randomized trial comparing bevacizumab alone versus bevacizumab plus vorinostat in adults with recurrent gliob…
-
CLINICAL_TRIALS research · 2016-09-22Clinical Trial Update: Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma
An update on a clinical trial studying neurological complications after radiotherapy for high-grade glioblastoma, with leukoencephalopathy l…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors [Phase 3]
A Phase 3 clinical trial comparing TransMID against standard treatment for Glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]
A phase 2 clinical trial evaluated temozolomide plus radiation with or without cediranib maleate in newly diagnosed glioblastoma and gliosar…
-
CLINICAL_TRIALS research · 2016-09-14Clinical Trial Update: MRI Detection of Microbleeds in Glioma Patients
A completed clinical trial update examining MRI detection of microbleeds in glioblastoma patients.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status [Phase 2]
A Phase 2 trial evaluating temozolomide in combination with bevacizumab in elderly patients (70 years and older) with supratentorial gliobla…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma [Phase 1]
A Phase 1 study evaluating lomustine for bevacizumab-naive recurrent malignant glioma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme [Phase 1]
Phase 1 pilot study evaluating autologous anti-EGFRvIII CAR T cells in recurrent glioblastoma; the document notes the trial status but provi…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma [EARLY_Phase 1]
An early Phase 1 study evaluated sunitinib concentrations in recurrent glioblastoma patients not taking enzyme-inducing antiepileptic drugs …
-
CLINICAL_TRIALS research · 2016-06-28Clinical Trial Update: Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients [Phase 2]
A Phase 2 clinical trial from Seoul National University Hospital is evaluating whether levetiracetam is beneficial for patients with newly d…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Bosutinib in Adult Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial results for bosutinib in adults with recurrent glioblastoma have been posted.
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas [NA]
An update on a clinical trial assessing whether magnetic resonance spectroscopy-guided resection improves prognosis for high-grade gliomas.